Medicare Enrolled

Dr. Abdul Abdellatif, M.D.

Internal Medicine · Webster, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
600 N KOBAYASHI STE 213, Webster, TX 77598
2817248296
In practice since 2007 (19 years)
NPI: 1164560595 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abdellatif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abdellatif? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abdellatif

Dr. Abdul Abdellatif is an internal medicine in Webster, TX, with 19 years in practice. Based on federal Medicare data, Dr. Abdellatif performed 27,514 Medicare services across 940 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abdellatif received a total of $2,066,724 from 50 pharmaceutical and/or device companies across 2549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abdellatif is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in TX$ $2,066,724 industry payments

Medicare Practice Summary

Medicare Utilization ↗
27,514
Medicare services
Top 2% in TX for internal medicine
940
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,448 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Romosozumab injection (Evenity) for osteoporosis16,800$8$38
Denosumab injection (Prolia/Xgeva)8,760$18$94
Hospital follow-up visit, high complexity374$93$359
Drug injection, under skin or into muscle250$11$70
Office visit, established patient, complex (40-54 min)217$119$540
Office visit, established patient (30-39 min)201$90$385
Dialysis services, 2-3 physician visits per month (20 years or older)191$230$881
Home dialysis services per month (20 years or older)180$229$880
Dialysis services, 1 physician visit per month (20 years or older)123$159$606
Dialysis services, 4 or more physician visits per month (20 years or older)121$250$1,060
Initial hospital admission, high complexity117$138$523
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less89$51$193
Hospital follow-up visit, moderate complexity75$59$239
New patient office visit, complex (60-74 min)16$178$664
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
96.0% medium
3.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,066,724
Total received (2018-2024)
Avg $295,246/year across 7 years
Top 0% in TX for internal medicine
50
Companies
2,549
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,033,800 (98.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$29,527 (1.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,397 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$303,280
2023
$315,848
2022
$444,326
2021
$275,220
2020
$181,735
2019
$348,605
2018
$197,711

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Horizon Therapeutics plc
$524,971
Mallinckrodt Hospital Products Inc.
$449,574
Amgen Inc.
$324,777
Aurinia Pharma U.S., Inc.
$182,921
Mallinckrodt Enterprises LLC
$126,192
Bayer HealthCare Pharmaceuticals Inc.
$115,562
Travere Therapeutics, Inc.
$81,119
Mallinckrodt LLC
$66,032
Vifor Pharma, Inc.
$47,083
Keryx Biopharmaceuticals, Inc.
$28,380
Relypsa, Inc.
$26,646
Janssen Pharmaceuticals, Inc
$22,608
GlaxoSmithKline, LLC.
$13,713
AKEBIA THERAPEUTICS INC
$10,898
Rockwell Medical, Inc.
$8,408
AstraZeneca Pharmaceuticals LP
$7,655
SOBI, INC
$7,631
Otsuka America Pharmaceutical, Inc.
$6,920
Bayer Healthcare Pharmaceuticals Inc.
$6,311
Baxter Healthcare
$3,166
Fresenius USA Marketing, Inc.
$2,194
Pharmacosmos Therapeutics Inc.
$1,609
BAXTER HEALTHCARE
$373
OPKO Pharmaceuticals, LLC
$225
Novartis Pharmaceuticals Corporation
$197
Alexion Pharmaceuticals, Inc.
$172
Alphatec Spine, Inc
$141
Phathom Pharmaceuticals, Inc.
$132
Lilly USA, LLC
$121
Novo Nordisk Inc
$117
Ardelyx, Inc.
$114
CALLIDITAS THERAPEUTICS US INC.
$100
Regeneron Pharmaceuticals, Inc.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$80
Corcept Therapeutics
$78
Exeltis, USA Inc.
$53
Daiichi Sankyo Inc.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
PFIZER INC.
$33
Merck Sharp & Dohme LLC
$30
Veloxis Pharmaceuticals, Inc.
$26
Abbott Laboratories
$26
SANOFI-AVENTIS U.S. LLC
$24
Alvogen Inc
$22
ABBVIE INC.
$21
Azurity Pharmaceuticals, Inc.
$20
GENZYME CORPORATION
$19
Dexcom, Inc.
$19
Alnylam Pharmaceuticals Inc.
$18
Shire North American Group Inc
$13
Top 3 companies account for 62.9% of total payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · AVYCAZ · Auryxia · BENLYSTA · BYDUREON · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Edarbyclor · Envarsus XR (SP) · FABRAZYME · FARXIGA · Fabhalta · FreeStyle Libre Pro · GATTEX · IBSRELA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · JESDUVROQ · JYNARQUE · KODIAK · KORSUVA · KRYSTEXXA · Kerendia · Korlym · LOKELMA · LUPKYNIS · MONOFERRIC · MOUNJARO · Monoferric · NATPARA (PARATHYROID HORMONE) · OFEV · OXLUMO · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVYMIS · PURIFIED CORTROPHIN GEL · Parsabiv · Perclose ProGlide suture mediated closure system · Prolia · RAYALDEE · RAYOS · Rayaldee · Renal - HD · Renal - PD · Repatha · SAMSCA · SOLIQUA · SYNAGIS · TARPEYO · TAVNEOS · TERIPARATIDE · TOLVAPTAN · TRADJENTA · TRIFERIC · Tavneos · Triferic · ULTOMIRIS · VOQUEZNA · Vafseo · Veltassa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.

Equivalent to $7,512 per 100 Medicare services performed
Looking for a internal medicine in Webster?
Compare internal medicines in the Webster area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
1,900
Per 100K population
39.9
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Abdellatif is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Abdellatif experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Abdellatif performed 16,800 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abdellatif receive payments from pharmaceutical companies?
Yes. Dr. Abdellatif received a total of $2,066,724 from 50 companies across 2,549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abdellatif's costs compare to other internal medicines in Webster?
Dr. Abdellatif's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abdellatif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →